Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • Drug Recall: Two lots of Naloxone injection recalled

    by
    • Optum Workers' Comp
    | Jun 06, 2018
    Tag Icon
    Workers' Compensation, Naloxone, FDA
    The U.S. Food and Drug Administration (FDA) announced that Hospira, Inc., a Pfizer company, voluntarily recalled two lots of naloxone hydrochloride injection at the hospital and institution level. Naloxone injection is used in the emergency treatment of a known or suspected opioid overdose. However, this recall does not affect the naloxone products Evzio® auto-injector or Narcan® Nasal Spray.


  • FDA approves first-in-class medication to prevent migraine

    by
    • Optum Workers' Comp
    | May 22, 2018
    Tag Icon
    Pain Management, FDA, Migraine
    The U.S. Food and Drug Administration (FDA) approved the first medication in a new class to prevent chronic migraine in adults. Aimovig™ (erenumab-aooe) will be marketed by Amgen Inc. as a self-administered, once monthly, subcutaneous (under the skin) injection.


  • FDA approves first non-opioid medication for opioid withdrawal symptoms

    by
    | May 17, 2018
    Tag Icon
    Workers' Compensation, Opioids
    the FDA approved Lucemyra™ (lofexidine hydrochloride) for the mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults.


  • National Prescription Drug Take Back Day Slated for April 28

    by
    • Optum Workers' Comp
    | Apr 17, 2018
    Tag Icon
    Overdose, DEA
    Saturday, April 28, from 10 a.m. to 2 p.m., is National Prescription Drug Take Back Day sponsored by the U.S. Drug Enforcement Administration (DEA). The purpose of National Prescription Drug Take Back Day is to provide a safe, convenient, and responsible way to dispose of prescription medications that are unwanted, unused, or expired, while also educating the public on the potential abuse of medications.